Antinociceptive, anti-inflammatory and antipyretic effects of 1.5-diphenyl-1H-Pyrazole-3-carbohydrazide, a new heterocyclic pyrazole derivative

Life Sci. 2014 Jan 30;95(2):81-8. doi: 10.1016/j.lfs.2013.12.005. Epub 2013 Dec 17.

Abstract

Aims: Heterocyclic pyrazole derivative has been described for the treatment of pain and inflammatory diseases. This study evaluated the in vivo, antinociceptive, anti-inflammatory and antipyretic effects of 1.5-diphenyl-1H-Pyrazole-3-carbohydrazide (1.5-DHP) and the in vivo or in vitro mechanism of action.

Main methods: Acetic acid-induced writhing, hot-plate and formalin-induced nociception tests were used to evaluate the antinociceptive effect, while the rota-rod test was used to assess the motor activity. Croton oil-induced ear edema and carrageenan-induced peritonitis tests were used to investigate the anti-inflammatory effect of 1.5-DHP. The antipyretic effect was assessed using the LPS-induced fever model. The mechanism of action was evaluated by PGE2 and TNF-α measurement and cyclooxygenase inhibition assay.

Key findings: Oral administration (p.o.) of 1.5-DHP (1, 3, 10 mg/kg) caused a dose-related inhibition of the acetic acid-induced writhing, however the highest dose was not effective on the hot-plate and rota-rod. In the formalin-induced nociception, 1.5-DHP (10mg/kg, p.o.) inhibited only the late phase of nociception. This same dose of 1.5-DHP also reduced the croton oil-induced ear edema. 1.5-DHP (3, 10, 30 mg/kg, p.o.) produced a dose-related reduction of leukocyte migration on the carrageenan-induced peritonitis. 1.5-DHP (60 mg/kg, p.o.) reduced the fever and the increase of PGE2 concentration in the cerebrospinal fluid induced by LPS. 1.5-DHP inhibited both COXs in vitro. Finally, 1.5-DHP (10 mg/kg, p.o.) reduced the TNF-α concentration in peritoneal exudates after carrageenan injection.

Significance: These results indicate that 1.5-DHP produces anti-inflammatory, antinociceptive and antipyretic effects by PGE2 synthesis reduction through COX-1/COX-2 inhibition and by TNF-α synthesis/release inhibition.

Keywords: 1.5-Diphenyl-1H-Pyrazole-3-carbohydrazide; Anti-inflammatory activity; Antinociceptive activity; Antipyretic activity; Cyclooxygenase; PGE(2); TNF-α.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analgesics* / chemistry
  • Analgesics* / pharmacology
  • Animals
  • Anti-Inflammatory Agents* / chemistry
  • Anti-Inflammatory Agents* / pharmacology
  • Antipyretics* / chemistry
  • Antipyretics* / pharmacology
  • Body Temperature / drug effects
  • Dinoprostone / genetics
  • Enzyme Activation / drug effects
  • Enzyme Inhibitors / pharmacology
  • Heterocyclic Compounds / chemistry
  • Heterocyclic Compounds / pharmacology
  • Male
  • Mice
  • Models, Animal
  • Motor Activity / drug effects*
  • Pyrazoles / chemistry*
  • Pyrazoles / pharmacology*
  • Rats
  • Rats, Wistar
  • Tumor Necrosis Factor-alpha / genetics

Substances

  • 1,5-diphenyl-1H-pyrazole-3-carbohydrazide
  • Analgesics
  • Anti-Inflammatory Agents
  • Antipyretics
  • Enzyme Inhibitors
  • Heterocyclic Compounds
  • Pyrazoles
  • Tumor Necrosis Factor-alpha
  • Dinoprostone